Allergic Rhinoconjunctivitis
📧 Sign up to get email alerts when something new happens for Allergic Rhinoconjunctivitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-07-20Clinical Trial Update: A Research Study of House Dust Mite (HDM) SLIT-tablet for the Treatment of HDM Allergy in Chinese Participants Aged 12-65 [Phase 3]
Phase 3 trial update for a house dust mite SLIT-tablet in Chinese participants with allergic rhinitis/rhinoconjunctivitis is ongoing but not…
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: Grass Pollen Immunotherapy Plus Dupilumab for Tolerance Induction [Phase 2]
Phase 2 trial evaluating grass pollen immunotherapy in combination with dupilumab for tolerance induction in allergic rhinoconjunctivitis an…
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Results: Grass Pollen Immunotherapy Plus Dupilumab for Tolerance Induction [Phase 2]
Phase 2 trial evaluating grass pollen immunotherapy combined with dupilumab for tolerance induction in allergic rhinoconjunctivitis and gras…
-
CLINICAL_TRIALS trial_result · 2026-02-23Clinical Trial Update: Retrospective Study Evaluating the Effectiveness and Safety of Immunotherapy With Clustoid Max Forte
A retrospective study evaluates the effectiveness and safety of Clustoid Max Forte immunotherapy for dust mite-related allergies. The condit…
-
CLINICAL_TRIALS trial_result · 2026-02-10Clinical Trial Update: Study of BLU-808 in Allergic Rhinoconjunctivitis [Phase 2]
A Phase 2 study of BLU-808 for allergic rhinoconjunctivitis has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-12-31Clinical Trial Update: A Research Study of House Dust Mite (HDM) SLIT-tablet for the Treatment of HDM Allergy in Chinese Participants Aged 12-65 [Phase 3]
A Phase 3 clinical trial evaluating a house dust mite sublingual immunotherapy tablet for allergic rhinitis/rhinoconjunctivitis in Chinese p…
-
CLINICAL_TRIALS trial_result · 2025-11-26Clinical Trial Update: Safety and Efficacy of STALORAL® Birch 300 IR in a Paediatric Population With Birch Pollen-induced ARC w/o Asthma [Phase 3]
Phase 3 trial evaluating the safety and efficacy of STALORAL Birch 300 IR in children with birch pollen-induced allergic rhinoconjunctivitis…
-
CLINICAL_TRIALS trial_result · 2025-08-29Clinical Trial Update: Dietary Supplement (Beta-Glucans) in Allergic Patients Undergoing Subcutaneous Immunotherapy. [Phase 4]
Phase 4 trial evaluating beta-glucans as an adjunct to subcutaneous immunotherapy in allergic rhinitis and asthma patients has completed.
-
CLINICAL_TRIALS trial_result · 2025-06-18Clinical Trial Update: A Motivation-enhancing App to Retain Patients With Hay Fever in a Trial After Treatment [NA]
This clinical trial update reports a completed study investigating a motivation-enhancing app aimed at retaining hay fever patients during a…
-
CLINICAL_TRIALS trial_result · 2025-05-21Clinical Trial Update: Immunological Analysis of Lymph Node Tissue After Intralymphatic Immunotherapy: A Prospective Case Control Study [EARLY_Phase 1]
An early Phase 1 trial from the University of Zurich evaluated immunological changes in lymph node tissue after intralymphatic immunotherapy…
-
CLINICAL_TRIALS research · 2025-05-13Clinical Trial Update: Efficacy and Safety Evaluation for the Treatment of Allergy Against Mites [Phase 3]
Ongoing Phase 3 clinical trial evaluating the efficacy and safety of mite allergen immunotherapy for allergic rhinitis/rhinoconjunctivitis a…
-
CLINICAL_TRIALS research · 2025-05-13Clinical Trial Update: Efficacy and Safety Evaluation of the Treatment of Allergy Against Cupressaceae and Grasses. [Phase 3]
A Phase 3 clinical trial evaluating the efficacy and safety of a treatment for allergies to Cupressaceae and grasses, including allergic rhi…
-
CLINICAL_TRIALS research · 2025-01-28Clinical Trial Update: Evaluation of the Efficacy of Allergen-specific Immunotherapy Using Assessment in an Allergen Exposure chamber-a Randomized Placebo-controlled Double-blind Study [Phase 4]
A Phase 4 randomized, double-blind trial is evaluating allergen-specific immunotherapy using an allergen exposure chamber for allergic rhino…
-
CLINICAL_TRIALS trial_result · 2024-12-16Clinical Trial Update: A Study in Adults With Grass Pollen-induced Rhinoconjunctivitis [Phase 3]
Phase 3 trial update in adults with grass pollen-induced rhinoconjunctivitis; results have been posted after study completion.
-
CLINICAL_TRIALS trial_result · 2024-06-18Clinical Trial Update: Andosan in Allergic and Asthma Patients [NA]
A completed clinical trial from University Hospital, Akershus evaluating Andosan in patients with allergic asthma and allergic rhinoconjunct…
-
CLINICAL_TRIALS trial_result · 2024-05-29Clinical Trial Update: Tolerability of Grazax in Patients With Hayfever in Real Life Settings [Phase 4]
Phase 4 trial update on tolerability of Grazax in real-life patients with hay fever.
-
CLINICAL_TRIALS trial_result · 2023-12-19Clinical Trial Update: Efficacy and Safety Evaluation for the Treatment of Asthma and Allergic Rhinitis/Rhinoconjunctivitis [Phase 3]
Phase 3 trial update evaluating efficacy and safety for allergic rhinitis/conjunctivitis; trial status terminated.
-
CLINICAL_TRIALS trial_result · 2023-10-23Clinical Trial Update: Clinical Trial to Evaluate the Efficacy and Safety of Polymerized, Mannan-Conjugated Dermatophagoides Allergen Extract [Phase 2, Phase 3]
Clinical trial update for a Phase 2/3 study evaluating a polymerized, mannan-conjugated Dermatophagoides allergen extract for allergic rhini…
-
CLINICAL_TRIALS trial_result · 2023-07-03Clinical Trial Update: Adolescent Mite Allergy Safety Evaluation [Phase 3]
Phase 3 safety evaluation for adolescents with mite allergy completed; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2022-11-18Clinical Trial Update: Efficacy and Safety Evaluation for the Treatment of HDM Induced Allergic Asthma and Rhinitis/Rhinoconjunctivitis [Phase 3]
Phase 3 clinical trial evaluating efficacy and safety for treatment of house dust mite–induced allergic asthma and perennial allergic rhinit…
-
CLINICAL_TRIALS trial_result · 2022-06-30Clinical Trial Update: A Research Study in Chinese People With Allergy to House Dust Mites, Using an Environmental Exposure Chamber [Phase 3]
Phase 3 clinical trial in Chinese participants with house dust mite allergy using an environmental exposure chamber has been terminated.
-
CLINICAL_TRIALS trial_result · 2021-02-26Clinical Trial Update: Texan Allergy & Sinus Center Mountain Cedar Intra-Lymphatic Immunotherapy Study [Phase 2]
Phase 2 clinical trial update for intra-lymphatic immunotherapy targeting tree pollen allergy shows completed status with posted results.
-
CLINICAL_TRIALS trial_result · 2020-08-21Clinical Trial Update: Efficacy and Safety of Norketotifen in Adults With Allergic Rhinitis [Phase 2]
Phase 2 trial update on the efficacy and safety of norketotifen in adults with allergic rhinitis and rhinoconjunctivitis.
-
CLINICAL_TRIALS trial_result · 2019-09-13Clinical Trial Update: Efficacy and Safety of SUBLIVAC Phleum for Immunotherapy of Grass Pollen-Allergy [Phase 2]
Phase 2 trial update on SUBLIVAC Phleum for grass pollen allergy shows efficacy and safety data, completed with posted results.
-
CLINICAL_TRIALS trial_result · 2019-05-06Clinical Trial Update: Subcutaneous Immunotherapy in Patients Sensitized to Dermatophagoides Pteronyssinus (DPT) [Phase 1]
Phase 1 trial evaluating subcutaneous immunotherapy in patients with allergic rhinoconjunctivitis sensitized to Dermatophagoides pteronyssin…